Ketamine clinic advertising and marketing
Ketamine infusion, Spravato, and emerging psychedelic-assisted therapy. Real demand, a narrow advertising surface, and a category where the wrong ad gets the clinic's whole account disabled.
Where this category loses
Ketamine is a prescription drug being advertised off-label. Naming it as a product, promising outcomes for depression, or using patient testimonials trips prescription-drug and health-claims rules. Psychedelic substances beyond ketamine cannot be advertised at all.
Creative and page rules
Do
Don't
Policy reality
Positions are the same cells as the Policy Tracker, with how we run each platform for this category underneath. Where a cell names a certification it is LegitScript, the third-party certification Meta and Google require before a pharmacy or telehealth provider can advertise prescription drugs, unless the cell says otherwise.
What we run
Set at kickoff, reported against weekly, measured by the tracking we install in week one.
Ketamine clinics questions
Clinic and consultation intent, yes. Keyword bidding on the drug itself and any outcome claims for depression or anxiety run into the healthcare and medicines policy. The campaign is built around the clinic, the treatment path, and candidacy.
Because the platforms restrict the product and the claims, the reachable audience through paid is smaller than the demand. Provider referral, organic search, and email carry more of the load than in most healthcare categories, which is why the plan includes them from day one.
Growth audit
We audit the funnel, the tracking, and the compliance posture, then hand you the roadmap. The people writing it have run the same funnel from the inside. You keep it whether or not we work together.